Athena Athena

X

Find Radio Compass News for Valsartan

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

JDMFs Filed

JDMFs Filed

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
193
INTERMEDIATES
DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

DIGITAL CONTENT

Blog #PharmaFlow

News

REF STANDARD

EDQM

USP

JP

Other Listed Suppliers

SERVICES
left grey arrow
right gray arrow
  • TABLET;ORAL - EQ 5MG BASE;80MG
  • TABLET;ORAL - 12.5MG;160MG
  • TABLET;ORAL - 12.5MG;320MG
  • TABLET;ORAL - 12.5MG;80MG
  • TABLET;ORAL - 25MG;160MG
  • TABLET;ORAL - 25MG;320MG
  • TABLET;ORAL - 160MG
  • TABLET;ORAL - 320MG
  • TABLET;ORAL - 40MG
  • TABLET;ORAL - 80MG
  • TABLET;ORAL - EQ 10MG BASE;160MG
  • TABLET;ORAL - EQ 10MG BASE;320MG
  • TABLET;ORAL - EQ 5MG BASE;160MG
  • TABLET;ORAL - EQ 5MG BASE;320MG
  • TABLET;ORAL - EQ 10MG BASE;12.5MG;160MG
  • TABLET;ORAL - EQ 10MG BASE;25MG;160MG
  • TABLET;ORAL - EQ 10MG BASE;25MG;320MG
  • TABLET;ORAL - EQ 5MG BASE;12.5MG;160MG
  • TABLET;ORAL - EQ 5MG BASE;25MG;160MG

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204382

FDA
11 Aug 2023

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/dr-reddys-cuts-price-of-cardiovascular-drug-cidmus/articleshow/97091194.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

ECONOMIC TIMES
19 Jan 2023

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/novartis-heart-drug-price-may-fall-by-60-on-generic-rollouts/articleshow/97102183.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

ECONOMIC TIMES
19 Jan 2023

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/hc-reserves-order-on-natcos-plea-over-patent-for-novartis-drug/articleshow/96920043.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst

ECONOMIC TIMES
11 Jan 2023

https://www.fiercepharma.com/pharma/novartis-pays-245m-settle-exforge-generic-pay-delay-lawsuits

Angus Liu FIERCE PHARMA
04 Jan 2023

https://health.economictimes.indiatimes.com/news/pharma/top-novartis-cardiac-drug-to-go-off-patent/95952280

ECONOMICTIMES
03 Dec 2022

https://www.business-standard.com/article/news-cm/iol-chemicals-secures-patent-for-invention-related-to-preparation-of-sartan-drugs-122112400926_1.html

BUSINESS-STANDARD
27 Nov 2022

https://www.raps.org/news-and-articles/news-articles/2022/10/prompted-by-recent-recalls-regulators-scramble-to

Joanne S. Eglovitch RAPS
31 Oct 2022

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210596

FDA
19 Sep 2022

https://www.fiercepharma.com/pharma/novartis-takes-entresto-generic-fight-fda-again-after-similar-appeal-flopped-april

Fraiser Kansteiner FIERCEPHARMA
17 Sep 2022

https://www.businesswire.com/news/home/20211209005397/en

BUSINESSWIRE
09 Dec 2021

https://www.fiercepharma.com/pharma-asia/biocon-viatris-insulin-biosimilar-astrazeneca-china-performance-huahai-fda-warning-lift

Angus Liu FIERCEPHARMA
19 Nov 2021

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/delhi-hc-restrains-generic-pharma-firms-from-making-selling-patent-drug-of-novartis/articleshow/87483290.cms

ECONOMICTIMES
03 Nov 2021

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214102

FDA
03 Nov 2021

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204038

FDA
30 Oct 2021

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204038

FDA
30 Oct 2021

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=201618

FDA
07 Oct 2021

https://www.newswire.ca/news-releases/advisory-multiple-lots-of-irbesartan-losartan-and-valsartan-drugs-recalled-due-to-azido-impurity-824128492.html

NEWSWIRE
17 Sep 2021

https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2021/75715a-eng.php

HEALTH CANADA
15 Jun 2021

https://www.novartis.com/news/novartis-entresto-indicated-treatment-hypertension-china

PRESS RELEASE
10 Jun 2021

https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2021/75703r-eng.php

HEALTH CANADA
27 May 2021

https://endpts.com/novartis-whiffs-on-entresto-study-after-heart-attacks-but-that-doesnt-mean-its-going-down-quietly/

K. Blankenship ENDPTS
17 May 2021

https://www.healio.com/news/cardiology/20210517/sacubitrilvalsartan-not-superior-to-valsartan-alone-in-advanced-hfref-life#:~:text=In%20patients%20with%20advanced%20HF,results%20of%20the%20LIFE%20trial.

HEALIO
17 May 2021

https://www.fiercepharma.com/pharma/novartis-entresto-falls-short-post-heart-attack-trial

Fraiser Kansteiner FIERCEPHARMA
27 Apr 2021

https://www.fiercepharma.com/marketing/where-do-you-stand-fda-reviewers-argue-for-novartis-entresto-committee-meeting-file

FIERCEPHARMA
14 Dec 2020

https://www.nytimes.com/2020/07/01/business/Novartis-kickbacks-diabetes-heart-drugs.html

Neil Vigdor NYTIMES
02 Jul 2020

https://www.news-medical.net/news/20200511/AI-VIVO-seeks-pharma-biotech-collaboration-partners-to-advance-drug-candidates-for-COVID-19.aspx

MEDICAL
10 May 2020

http://www.pmlive.com/pharma_news/cosentyx,_entresto_drive_topline_growth_for_novartis_in_q4_1323659

Lucy Parsons PMLIVE
30 Jan 2020

https://www.fiercepharma.com/manufacturing/year-ahead-fpm-story

Eric Palmer FIERCE PHARMA
19 Dec 2019

https://www.business-standard.com/article/pti-stories/sun-pharma-gets-partial-relief-from-us-court-in-litigation-involving-three-generic-drugs-119120200818_1.html

BUSINESS-STANDARD
03 Dec 2019

https://www.prnewswire.com/news-releases/novartis-paragon-hf-analyses-suggest-entresto-benefit-beyond-hfref-300959592.html

PR NEWSWIRE
18 Nov 2019

https://www.fiercepharma.com/manufacturing/fda-warning-letter-tags-torrent-as-key-offender-production-tainted-blood-pressure

Eric Palmer FIERCE PHARMA
17 Oct 2019

https://www.biospace.com/article/6-major-drug-recalls-in-the-past-for-health-concerns/?s=95

Charlie Harper BIOSPACE
17 Oct 2019

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/mylan-to-invest-1-billion-in-india-on-capex-in-6-years/articleshow/71358699.cms

THE ECONOMIC TIMES
29 Sep 2019

https://www.pharmacompass.com/pdf/news/fda-confirms-paragraph-iv-patent-challenge-of-entresto-207620-sacubitril-and-valsartantablets-24-mg26-mg-49-mg51-mg-97-mg103-mg-1569473893.pdf

FDA
26 Sep 2019

https://www.cnbc.com/2019/09/13/fda-finds-impurity-in-heartburn-medicine-zantac-that-could-cause-cancer.html

Mallika Mitra CNBC
14 Sep 2019

https://www.raps.org/news-and-articles/news-articles/2019/9/ema-begins-testing-heartburn-medicines-for-carcino

Zachary Brennan RAPS
13 Sep 2019

https://www.nbcnews.com/health/health-care/u-s-officials-worried-about-chinese-control-american-drug-supply-n1052376?cid=public-rss_20190912

NBCNEWS
13 Sep 2019

https://www.fiercepharma.com/manufacturing/aurobindo-recalls-mislabeled-statin-tablets-off-u-s-market

K. Blankenship FIERCE PHARMA
10 Sep 2019

https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205347

FDA
05 Sep 2019

https://www.reuters.com/article/us-fda-valsartan/fda-says-widening-probe-on-generic-drug-impurities-idUSKCN1VI1RH

Michael Erman REUTERS
29 Aug 2019

https://www.in-pharmatechnologist.com/Article/2019/08/14/The-sartan-saga-Recapping-the-recalls

Maggie Lynch IN-PHARMATECHNOLOGY
15 Aug 2019

https://www.raps.org/news-and-articles/news-articles/2019/8/ndea-and-ndma-impurities-another-indian-manufactu

Zachary Brennan RAPS
13 Aug 2019

http://www.pharmafile.com/news/525299/novartis-entresto-falls-short-phase-3-heart-failure-preserved-ejection-fraction

PHARMAFILE
25 Jul 2019

https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/us-fda-finds-significant-violations-at-indias-strides-plant/articleshow/70256012.cms

ECONOMIC TIMES
16 Jul 2019

https://www.raps.org/news-and-articles/news-articles/2019/7/manufacturing-concerns-lead-fda-to-pull-31-apotex?feed=Regulatory-Focus

Zachary Brennan RAPS
09 Jul 2019

https://www.fiercepharma.com/manufacturing/aurobindo-gets-warning-letter-over-valsartan-recall-mess

Eric Palmer FIERCE PHARMA
03 Jul 2019

https://www.raps.org/news-and-articles/news-articles/2019/7/fda-sends-warning-letters-to-aurobindo-api-repack?feed=Regulatory-Focus

Michael Mezher RAPS
03 Jul 2019

https://www.fiercepharma.com/pharma/big-pharma-hits-3b-payments-to-doctors-and-teaching-hospitals-cms

Kyle Blankenship FIERCE PHARMA
02 Jul 2019

https://www.fiercepharma.com/manufacturing/pharmacy-takes-fda-to-task-citizen-petition-over-tainted-valsartan

Eric Palmer FIERCE PHARMA
20 Jun 2019
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY